Abstract:Bacteriophages offer a promising alternative to conventional antimicrobial treatments, particularly in cases where such treatments have proven ineffective. While naturally occurring phages serve as viable options for phage therapy, advances in synthetic biology and genome engineering enable precise modifications to phages to enhance their therapeutic potential. One such approach is the introduction of antimicrobial genetic payloads into the phage genome. Conventional practice is to integrate such payloads behind genes expressed at very high levels late in the infection cycle, such as the major capsid gene (cps). Nevertheless, phages engineered to contain antimicrobial payloads are often difficult to obtain. For instance, the high expression of toxic payloads can prematurely halt host metabolism, leading to the failure in assembling viable phage progeny. To potentially expand the range of genes viable as genetic payloads, we developed a method to identify intergenic loci with favorable expression levels. We used the machine learning (ML)-based promoter prediction algorithm PhagePromoter to identify these loci. We then used this information to design a computationally-assisted engineering pipeline for the integration of genomic payloads at these locations. We validated our approach experimentally, engineering phages with bioluminescent reporter payloads at various predicted loci. We used the well characterized, strictly lytic, Staphylococcus aureus-infecting bacteriophage, K, as an engineering scaffold and employed homologous recombination to engineer three recombinant phages containing the reporter payload at different predicted loci throughout the genome. The recombinant phages exhibited expression levels consistent with our computational predictions and showed temporal expression patterns corresponding to their genomic locations in early, middle, or late gene clusters. Our study underscores the potential of integrating computational tools with classical sequence analysis to streamline the phage engineering process. This approach not only facilitates the rational design of phages with targeted payload insertions but also paves the way for high-throughput, automated phage engineering, fostering a new era of personalized phage therapy.

Cell-Targeted Phagemid Particles Preparation Using Escherichia Coli Bearing Ligand-Piii Encoding Helper Phage Genome

Preparation of Peptide-Targeted Phagemid Particles Using a Protein III-modified Helper Phage.

Construction of a low molecular weight plasmid vector for the capture of genes encoding exported proteins.

A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells

Visualization of Engineered M13 Phages Bound to Bacterial Targets by Transmission Electron Microscopy

Development of Efficient Rna Interference System Using Egf-Displaying Phagemid Particles

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

A novel one-step method for targeted multiplication of DNA fragments from the Escherichia coli chromosome mediated by coordinated functioning of λ and φ80 bacteriophage recombination systems

Protein Iii-Based Single-Chain Antibody Phage Display Using Bacterial Cells Bearing an Additional Genome of A Gene-Iii-Lacking Helper Phage

Phage Particles of Controlled Length and Genome for In Vivo Targeted Glioblastoma Imaging and Therapeutic Delivery

Expression and purification of phage T7 ejection proteins for cryo-EM analysis

PHEIGES: all-cell-free phage synthesis and selection from engineered genomes

Cloning, expression and sequencing of a DNA fragment having E. coli promoter funcation from phage Mph1 attacking Micromonospora purpurea

Generation of Antibody Libraries for Phage Display: Preparation of Electrocompetent E. coli

Plasmid-coded DNA fragment developed as a specific gene probe for the identification of enteroaggregative Escherichia coli.

Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene E.

Bio-modification of M13 bacteriophage as signal amplification container for the highly sensitive detection of live E. Coli

[Construction of Efficient Conjugal Plasmids Between Escherichia Coli and Streptomycetes].

Computational pipeline for targeted integration and variable payload expression for bacteriophage engineering.

Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering

Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018